loadpatents
Patent applications and USPTO patent grants for LEVY; Daniel E..The latest application filed is for "polymorphic form of sepiapterin".
Patent | Date |
---|---|
Polymorphic Form Of Sepiapterin App 20220081443 - YOSHINO; Hiroshi ;   et al. | 2022-03-17 |
Method For Preparing And Delivering Bisantrene Formulations App 20210379021 - LEVY; Daniel E. ;   et al. | 2021-12-09 |
Polymorphs Of Sepiapterin And Salts Thereof App 20210300930 - LEVY; Daniel E. | 2021-09-30 |
Polymorphic form of sepiapterin Grant 11,130,760 - Yoshino , et al. September 28, 2 | 2021-09-28 |
Pharmaceutically Acceptable Salts Of Sepiapterin App 20210269443 - LEVY; Daniel E. ;   et al. | 2021-09-02 |
Polymorphs of sepiapterin and salts thereof Grant 11,072,614 - Levy July 27, 2 | 2021-07-27 |
Nanoparticles For Transfection App 20210180089 - VENABLES; Andrew ;   et al. | 2021-06-17 |
Dicarboxylic Fatty Acid Dimers, And Derivatives Thereof, As Standards For Quantifying Levels In Biospecimens App 20200199038 - Jayasinghe; Dushmanthi ;   et al. | 2020-06-25 |
Pharmaceutical Compositions Comprising Sepiapterin And Uses Thereof App 20200061070 - LEVY; Daniel E. | 2020-02-27 |
Polymorphic Form Of Sepiapterin App 20200010469 - YOSHINO; Hiroshi ;   et al. | 2020-01-09 |
Polymorphs Of Sepiapterin And Salts Thereof App 20190308975 - LEVY; Daniel E. | 2019-10-10 |
Adenylyl cyclase inhibitors, pharmaceutical compositions and method of use thereof Grant 10,081,633 - Levy , et al. September 25, 2 | 2018-09-25 |
CaMKII inhibitors and uses thereof Grant 9,951,061 - Levy , et al. April 24, 2 | 2018-04-24 |
Adenylyl Cyclase Inhibitors, Pharmaceutical Compositions And Method Of Use Thereof App 20170362235 - Levy; Daniel E. ;   et al. | 2017-12-21 |
C-20 Steroid Compounds, Compositions And Uses Thereof To Treat Traumatic Brain Injury (tbi), Including Concussions App 20160168190 - Levy; Daniel E. | 2016-06-16 |
Synthesis Of Ent-progesterone And Intermediates Thereof App 20160108081 - Levy; Daniel E. ;   et al. | 2016-04-21 |
CaMKII INHIBITORS AND USES THEREOF App 20160024078 - Levy; Daniel E. ;   et al. | 2016-01-28 |
Synthesis Of Ent-progesterone And Intermediates Thereof App 20150175650 - Levy; Daniel E. ;   et al. | 2015-06-25 |
Heterobifunctional Polyethylene Glycol Reagents App 20110282093 - Levy; Daniel E. ;   et al. | 2011-11-17 |
Methods and compositions for treating diseases associated with pathogenic proteins App 20070179123 - Chiang; Peter K. ;   et al. | 2007-08-02 |
4-thieno[2,3-D]pyrimidin-4-YL piperazine compounds Grant 7,115,741 - Levy , et al. October 3, 2 | 2006-10-03 |
Piperazine and homopiperazine compounds App 20030153556 - Levy, Daniel E. ;   et al. | 2003-08-14 |
Process for preparing synthetic matrix metalloprotease inhibitors Grant 5,892,112 - Levy , et al. | 1999-04-06 |
Sialyl Lewis.sup.x mimetics containing phenyl backbones Grant 5,789,385 - Anderson , et al. August 4, 1 | 1998-08-04 |
Synthetic matrix metalloprotease inhibitors and use thereof Grant 5,773,438 - Levy , et al. June 30, 1 | 1998-06-30 |
Sialic acid/fucose based medicaments Grant 5,658,880 - Dasgupta , et al. August 19, 1 | 1997-08-19 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.